Hepatitis C and hepatocellular carcinoma (WP3646)
Pathway model based on hub miRNAs and their putative targets from network analysis. * From a set of differentially expressed genes in both chronic HCV (hepatitis C virus) and HCC (hepatocellular carcinoma) samples, a protein-protein network was constructed using STRING (http://string-db.org/) and GeneMANIA (http://genemania.org/). * After topological analysis and network visualization in Cytoscape, the top hub genes were identified. * miRNAs related to hub genes were identified using miRTarBase server and combined with the PPI network to constructed a miRNA-Hubgene network. Based on Figure 4 from Poortahmasebi et al, How Hepatitis C Virus Leads to Hepatocellular Carcinoma: A Network-Based Study. Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP3646 CPTAC Assay Portal]
AuthorsKristina Hanspers , Jonathan Mélius , Andika Tan , Martina Summer-Kutmon , Egon Willighagen , and Eric Weitz
Discuss this pathway
Check for ongoing discussions or start your own.
- Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients (2022).
- The Biological Interaction of SARS-CoV-2 Infection and Osteoporosis: A Preliminary Study (2022).
- IL6-mediated HCoV-host interactome regulatory network and GO/Pathway enrichment analysis (2020).
- GediNET for discovering gene associations across diseases using knowledge based machine learning approach (2022).
Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.
Disease Ontologyhepatocellular carcinoma
Pathway Ontologydisease pathway
- How Hepatitis C Virus Leads to Hepatocellular Carcinoma: A Network-Based Study. Poortahmasebi V, Poorebrahim M, Najafi S, Jazayeri SM, Alavian SM, Arab SS, et al. Hepat Mon. 2016 Feb 20;16(2):e36005. PubMed Europe PMC Scholia